Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Denver news in your inbox

Catch up on the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Des Moines news in your inbox

Catch up on the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Minneapolis-St. Paul news in your inbox

Catch up on the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tampa Bay news in your inbox

Catch up on the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Charlotte news in your inbox

Catch up on the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

AP Photo/Jim Mone, File

Hound Labs, an Oakland-based maker of a breathalyzer that measures marijuana, announced Tuesday that it has raised $8.1 million in venture capital funding led by Benchmark (early investor in companies like Uber and Snap).

The problem: THC, the active ingredient in marijuana, can remain in a user's system for days (perhaps even weeks) after the period of impairment. That means traditional THC tests ― hair, urine, blood, etc. ― are less valuable in an era of increased legalization. What's key is knowing if someone is driving high, or comes to work high.

Solution: Hound Labs says that its breathalyzer measures THC molecules in breath at parts per million, as opposed to alcohol breathalyzers than analyze in parts per thousand. The company currently in conducting both clinical tests (in partnership with UCSF) and field tests.

How much is too much? There are not currently any legal breath standards for marijuana, so Hound Labs is basically replicating what was done with alcohol breathalyzers decades ago. Co-founder and CEO Mike Lynn (a former ER doctor and reserve deputy sheriff) tells Axios: "We get people high and have them drive in a controlled environment, to see what levels cause actual impairment."

Marijuana money: Hound Labs plans to create a recurring revenue model, by selling the device and then requiring a new cartridge for each test. Lynn says that the cartridge chemistry is "extremely stable," we means that they can be re-tested at a later date, so as to prevent wrongful prosecution or job termination.

Fun fact: Law & Order producer Dick Wolf is an early Hound Labs investor, and follow-on participant in the $8.1 million round.

Go deeper

Updated 6 hours ago - Politics & Policy

Coronavirus dashboard

Illustration: Eniola Odetunde/Axios

  1. Health: Most vulnerable Americans aren't getting enough vaccine information — Fauci says Trump administration's lack of facts on COVID "very likely" cost lives.
  2. Politics: Biden unveils "wartime" COVID strategyBiden's COVID-19 bubble.
  3. Vaccine: Florida requiring proof of residency to get vaccine — CDC extends interval between vaccine doses for exceptional cases.
  4. World: Hong Kong to put tens of thousands on lockdown as cases surge.
  5. Sports: 2021 Tokyo Olympics hang in the balance.
  6. 🎧 Podcast: Carbon Health's CEO on unsticking the vaccine bottleneck.

Trump impeachment trial to start week of Feb. 8, Schumer says

Senate Majority Leader Chuck Schumer. Photo: The Washington Post via Getty

The Senate will begin former President Trump's impeachment trial the week of Feb. 8, Majority Leader Chuck Schumer announced Friday on the Senate floor.

The state of play: Schumer announced the schedule after reaching an agreement with Republicans. The House will transmit the article of impeachment against the former president late Monday.

8 hours ago - Health

CDC extends interval between COVID vaccine doses for exceptional cases

Photo: Joseph Prezioso/AFP via Getty

Patients can space out the two doses of the coronavirus vaccine by up to six weeks if it’s "not feasible" to follow the shorter recommended window, according to updated guidance from the Centers for Disease and Control and Prevention.

Driving the news: With the prospect of vaccine shortages and a low likelihood that supply will expand before April, the latest changes could provide a path to vaccinate more Americans — a top priority for President Biden.